BC

Boxer Capital Portfolio holdings

AUM $2.04B
1-Year Est. Return 108.35%
This Quarter Est. Return
1 Year Est. Return
+108.35%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.9B
AUM Growth
-$126M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
63
New
Increased
Reduced
Closed

Top Buys

1 +$18.5M
2 +$17M
3 +$13.8M
4
CGEM icon
Cullinan Oncology
CGEM
+$11.5M
5
SYRE icon
Spyre Therapeutics
SYRE
+$10.5M

Top Sells

1 +$24.6M
2 +$2.55M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$15.2B
$166M 8.75%
4,279,464
SWTX
2
DELISTED
SpringWorks Therapeutics
SWTX
$129M 6.79%
3,421,541
CYTK icon
3
Cytokinetics
CYTK
$8.16B
$114M 5.99%
2,100,000
MRUS icon
4
Merus
MRUS
$7.3B
$112M 5.92%
1,900,000
TYRA icon
5
Tyra Biosciences
TYRA
$1.17B
$103M 5.43%
6,448,359
SRPT icon
6
Sarepta Therapeutics
SRPT
$2.39B
$103M 5.41%
650,000
NUVL icon
7
Nuvalent
NUVL
$8.31B
$85M 4.48%
1,120,192
IDYA icon
8
IDEAYA Biosciences
IDYA
$3.15B
$77.3M 4.07%
2,202,812
ONC
9
BeOne Medicines Ltd
ONC
$36.7B
$71.3M 3.76%
500,000
RNA icon
10
Avidity Biosciences
RNA
$10.8B
$70.6M 3.72%
1,727,388
TNGX icon
11
Tango Therapeutics
TNGX
$1.33B
$70.3M 3.7%
8,198,642
APLS icon
12
Apellis Pharmaceuticals
APLS
$2.79B
$66.2M 3.49%
1,726,000
ITOS
13
DELISTED
iTeos Therapeutics
ITOS
$43.7M 2.3%
2,946,915
+1,142,857
ARGX icon
14
argenx
ARGX
$56.4B
$43M 2.26%
100,000
AKRO icon
15
Akero Therapeutics
AKRO
$4.49B
$39.3M 2.07%
1,676,733
NKTX icon
16
Nkarta
NKTX
$131M
$33.1M 1.75%
5,607,350
ANAB icon
17
AnaptysBio
ANAB
$1.19B
$32.6M 1.72%
1,300,000
AXSM icon
18
Axsome Therapeutics
AXSM
$7.48B
$32.2M 1.7%
400,000
RCKT icon
19
Rocket Pharmaceuticals
RCKT
$370M
$31.6M 1.66%
1,466,051
FATE icon
20
Fate Therapeutics
FATE
$127M
$26.9M 1.42%
8,215,910
LEGN icon
21
Legend Biotech
LEGN
$5.15B
$26.6M 1.4%
600,000
THRD
22
DELISTED
Third Harmonic Bio
THRD
$26M 1.37%
2,000,000
GERN icon
23
Geron
GERN
$804M
$25.4M 1.34%
6,000,000
RCUS icon
24
Arcus Biosciences
RCUS
$3.13B
$24.4M 1.29%
1,602,200
XENE icon
25
Xenon Pharmaceuticals
XENE
$3.45B
$23.4M 1.23%
600,000